In the SCLC cell line H69, CSF2 was found to regulate phenotypic plasticity by phosphorylating the STAT3/MYC pathway, restricting the transition between adherent (H69A) and suspension (H69S) phenotypes and altering drug sensitivity in specific cell clones (117). The gene discussed is STAT3; the disease is small cell lung carcinoma.